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ABSTRACT 
Background: The triglyceride and glucose index (TyG index) has become an attractive 
option due to the highly available and inexpensive biochemical markers for the diagnostic of 
insulin resistance (IR). This study aimed to investigate the association between TyG index 
and parameters of metabolic syndrome patients.  
Method: A cross-sectional was conducted in outpatient Polyclinics of the Endocrine-
Metabolic division of RSUP H Adam Malik Medan. Criteria of Metabolic Syndrome 
(according to the new IDF definition, for a person to be defined as having the metabolic 
syndrome they must have: 
Central obesity plus any two of the following four factors): (i) abdominal obesity: waist 
circumference of ≥80 cm in women and ≥90 cm in men in ASEAN, measured at the umbilical 
level in a standing position; (ii) systolic blood pressure (SBP) of ≥130 mmHg or diastolic 
blood pressure (DBP) of ≥85 mmHg (or treatment with antihypertensive medication), 
measured in all subjects using a validated digital electronic tensiometer in both upper limbs 
in a seated position after 15 minutes of rest; (iii) triglycerides levels (TG) of ≥150 mg/dL (1.7 
mmol/L) or statin/fibrate treatment; HDL-cholesterol levels (HDL-C) of <50 mg/dL in 
women and <40 mg/dL in men.  
Result: Based this study, there were 20 metabolic syndrome patients.  From the data, all 
patients are obese and HbA1c is normal. There is a significant relationship between TyG and 
HDL-C and TG (r=-0.60; p=0.005** and r=0.88, p= 0.001**, respectively).  
Conclusion: There is a significant relationship between TyG and HDL-C and TG of 
metabolic syndrome patients. 
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ABSTRAK 
Latar Belakang : Triglyceride and glucose index (TyG index) menjadi pilihan penanda 
biokimia yang menarik, tersedia dan murah untuk mendiagnosa  resistensi insulin (RI). 
Tujuan penelitian ini adalah untuk menyelidiki hubungan antara indeks TyG dan parameter 
pasien sindrom metabolik.  
Metode:  Penelitian dilakukan secara potong lintang di Poliklinik rawat jalan Divisi 
Endokrine-Metabolik RSUP H Adam Malik Medan. Kriteria  sindrom metabolik (menurut 
IDF, seseorang didefinisikan sebagai memiliki sindrom metabolik yang harus memiliki 
obesitas sentral ditambah dua dari empat faktor berikut): (i) obesitas: lingkar pinggang ≥80 
cm pada wanita dan ≥90 cm pada pria Asia, diukur pada tingkat umbilical dalam posisi 
berdiri; (ii) tekanan darah systolik (TDS) ≥130 mmHg atau tekanan darah diastolik (TDD) 
≥85 mmHg (atau dengan pengobatan obat antihypertensif), diukur di semua subjek 
menggunakan tensiometer elektronik digital yang divalidasi di kedua anggota badan atas 
dalam posisi duduk setelah 15 menit istirahat; (iii) kadar trigliserida (TG) ≥150 mg/dL (1,7 
mmol/L) atau mendapat pengobatan statin/fibrate; Kadar kolesterol HDL (HDL-C) <50 
mg/dL pada wanita dan < 40 mg/dL pada pria).  
Hasil: Dari penelitian 20 pasien sindrom metabolik, semua pasien adalah obesitas dan 
normal HbA1c. Ada hubungan yang signifikan antara TyG dan HDL dan TG  (masing-
masing r=-0,60;p=0,005** dan r=0,88, p=0,001**).  
Kesimpulan: Ada hubungan yang signifikan antara TyG dengan HDL dan TG pada pasien 
sindrom metabolik. 
 
Kata Kunci: TyG, Parameter Sindrom Metabolik 
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1 Introduction 
Insulin resistance (IR) is one of the first metabolic abnormalities leading to the development of 
type 2 diabetes, and it is known to be a key mediator of its pathogenesis [1]. The 
hyperinsulinemic-euglycemic clamp (HIEC) is considered the current gold standard to determine 
IR [2]; however, it is a complicated and time-consuming method with limited applicability to 
research settings. As an alternative strategy, surrogate markers derived from faster and less costly 
biochemical measurements have been proposed [2, 3]. To date, several IR surrogate markers such 
as HOMA-IR, TG/HDL, QUICKI, and the McAuley index have been studied with different 
sensitivities and specificities for IR [4,5].  
Lately, the triglyceride and glucose index (TyG index) has become an attractive option due to the 
highly available and inexpensive biochemical markers needed for its calculation [6, 7]. It is 
derived from fasting plasma glucose and fasting triglyceride levels. The diagnostic accuracy of 
the TyG index in identifying IR using the HIEC and HOMA-IR as reference standards has been 
tested in several studies. However, the lack of consistency in their findings limits its 
generalizability and utility as a diagnostic marker of IR. Therefore, we sought to conduct a 
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systematic review to assess the body of evidence regarding the diagnostic accuracy of the TyG 
index in identifying IR in adults.  
Another risk factor for CVD in DMT2 is diabetic dyslipidemia. It consists of increased 
triglycerides (TG), reduced high-density lipoprotein cholesterol (HDL-C), and postprandial 
lipemia. In addition, low-density lipoprotein cholesterol (LDL-C) is converted to small, dense 
LDL that is more atherogenic. The serum triglyceride to high-density lipoprotein cholesterol (TG/ 
HDL-C) ratio, known as the atherogenic index of plasma, is one of the major risk factors for CVD 
and metabolic syndrome [8].  Higher TG/HDL C ratio has been associated with the presence of 
endothelial dysfunction [9]. Furthermore, TG/HDL-C ratio has been proposed as a marker of 
insulin resistance[10]. Quispe et al. [11] have shown that TG/HDL-C can also be a marker of 
glycemic control, especially in obese patients with DM2. An additional marker associated with 
insulin resistance is the triglyceride to glucose (TyG) index. It helps in the identification of 
subjects at high risk of CVD in asymptomatic subjects with DM2 [12].  
This study aimed to investigate the association between TyG index and parameters of metabolic 
syndrome patients.  
2 Method 
A cross-sectional was conducted in outpatient polyclinics of the Endocrine-Metabolic division of 
RSUP H Adam Malik Medan. The study group consisted of 20 patients with diagnosed metabolic 
syndrome. Anthropometric measurements (height, weight, and waist circumference) were taken 
in all subjects. Body mass index (BMI) was calculated as body weight (in kilograms) divided by 
the square of body height (in meters). The main analysis was performed using the 2009 revision 
of the International Diabetes Federation (IDF) definition, requiring the presence of the following 
criteria: (i) abdominal obesity: waist circumference of ≥80 cm in women and ≥90 cm in men in 
ASEAN, measured at the umbilical level in a standing position; (ii) systolic blood pressure (SBP) 
of ≥130 mmHg or diastolic blood pressure (DBP) of ≥85 mmHg (or treatment with 
antihypertensive medication), measured in all subjects using a validated digital electronic 
tensiometer in both upper limbs in a seated position after 15 minutes of rest; (iii) triglycerides 
levels (TG) of ≥150 mg/dL (1.7 mmol/L) or statin/fibrate treatment; HDL-cholesterol levels 
(HDL-C) of <50 mg/dL in women and <40 mg/dL in men. Diabetes was defined as fasting blood 
glucose (FBG) levels of ≥7 mmol/L and/or treatment with antidiabetic medications. Lipid profile 
examination is carried out using a spectrophotometer tool colorimetric enzymatic method or 
CHOD PAP parameters observed include total cholesterol, HDL cholesterol (High-Density 
Lipoprotein), LDL cholesterol (Low-Density Lipoprotein), and triglycerides [13]. 
According to a study by Salazar et al. insulin resistance cut-off is placed at the TyG index value 
of 4.49, with a sensitivity of 82.6% and specificity of 82.1% (AUC=0.889, 95% CI: 0.854-0.924). 
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Subjects with an index of 4.49 or greater are likely to suffer from insulin resistance.The TyG 
equation  = ln [Fasting triglyceride (mg / dl) x Fasting glucose (mg / dl)] /2. [14] 
Statistical Analysis 
SPSS 22.0 was employed for statistical analysis, and quantitative data were expressed in the form 
of (X  ±  SD). Nonparametric tests are used to calculate the correlation between TyG and 
metabolic syndrome parameters, and p  < 0 05 was accepted as statistically significant. 
3 Result  
Based in this study, there were 20 metabolic syndrome patients.  From the data, all patients are 
obese and HbA1c is normal (Table 1). 






Based in table 2. There is a significant relationship between TyG and HDL-C and TG of parameter 
of metabolic syndrome.     
Table 2 Relationship between TyG and parameter of metabolic syndrome 









Parameters X±SD (n=20) 
BMI (kg/m2) 34.2±5.6 
WC (cm) 98.4±11.1 
SBP (mmHg) 127.0±20.2 
DBP (mmHg 81.7±10.9 
FG (mg/dl) 85.3±9.0 
PPG (mg/dl) 105.0±22.3 
HbA1c (%) 5.6±0.4 
HDL-C (mg/dl) 48.8±16.43 
TG (mg/dl) 152.8±66.6 
TyG index 4.8±0.7 
Parameters r p 
BMI (kg/m2) 0.19 0.401 
WC (cm) 0.33 0.147 
SBP (mmHg) -0.25 0.277 
DBP (mmHg -0.41 0.072 
FG (mg/dl) 0.31 0.176 
PPG (mg/dl) -0.20 0.376 
HbA1c (%) 0.27 0.248 
HDL-C (mg/dl) -0.60 0.005** 
TG (mg/dl) 0.88 0.001** 
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4 Discussion 
The hyperinsulinemic-euglycemic clamp (HIEC) and HOMA-IR were used as the reference 
standard in the majority of the studies. Diagnostic accuracy varied according to the reference 
standard and the definition used to identify IR. In studies using HIEC, diagnostic performance 
varied with the insulin infusion rate and cutoff value. The highest sensitivity (96%) achieved with 
a moderate specificity (85%) was found with an insulin  rate of 40 μU/ min/m2 and a cutoff value 
of 2.8 insulin mg/min/kg [15]. The TyG index has been linked to conditions such as metabolic 
syndrome, type 2 diabetes, and the risk of developing cardiovascular disease. Based on the above, 
studies that standardize and evaluate the TyG index capacity as an IR diagnostic marker should 
be encouraged. However, its applicability is limited due to the marked heterogeneity found in 
cutoff values and IR definitions among studies. Identifying subjects with IR is fundamental to 
develop novel treatments and preventive strategies for highly prevalent chronic diseases related 
to IR, such as obesity and type 2 diabetes [16].  The TyG index showed a strong diagnostic 
performance for cardiovascular risk factors and was independently associated with the SYNTAX 
score. The risk of MACEs significantly increased in the high TyG index group as compared with 
the low TyG index group [17]. In this study, the TyG index correlated significantly with TG and 
HDL-C of the parameters of metabolic syndrome patients. 
5 Conclusion. 
TyG is significantly correlated only with TG and HDL-C in metabolic syndrome patients. 
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